Trial Profile
Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Thymalfasin (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- 02 Apr 2019 Status changed from recruiting to completed.
- 19 Sep 2016 New trial record